AstraZeneca Pharma Gains CDSCO Approval for Durvalumab Importation
Sep 25, 2024
Oncology Invest Information
Novartis's Kisqali Demonstrates a 28.5% Decrease in Recurrence Risk in Early Breast Cancer Patients
Sep 17, 2024
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma
Apr 29, 2024
BioNTech Projects Ten Oncology Trials by End of 2024 Leading to First Launch in 2026
Mar 20, 2024
Mainz Biomed Launches Physician-Led Lab in Germany Targeting Privately Insured Patients
Feb 7, 2024
SOPHiA GENETICS Partners with Karkinos Healthcare to Transform Cancer Care in India
Jan 15, 2024
Novartis Scemblix® Outperforms Traditional TKIs in Phase III CML Trial
Jan 8, 2024
Bristol Myers Squibb's Repotrectinib Under EMA Review for NSCLC Treatment
Jan 4, 2024
Alpha Tau Medical Highlights Landmark Achievements at J.P. Morgan Healthcare Conference
Dec 20, 2023
Alpha Tau Medical to Showcase Advances at the Upcoming J.P. Morgan Healthcare Conference
Dec 20, 2023
Stock Market Movers: Space, Entertainment, and Pharma Shares See Major Activity
Nov 9, 2023